Stanček, D., Fuchsberger, N., Oltman, M., Schmeisser, H., Kontsek, P., Jahnová, E., & Hajnická, V. Significance of anti-interferon-alfa 2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alfa 2.
Chicago Style (17th ed.) CitationStanček, D., Norbert Fuchsberger, M. Oltman, H. Schmeisser, Peter Kontsek, Eva Jahnová, and Valéria Hajnická. Significance of Anti-interferon-alfa 2 and SICAM-1 Activities in the Sera of Viral Hepatitis B and C Patients Treated with Human Recombinant Interferon-alfa 2.
MLA (9th ed.) CitationStanček, D., et al. Significance of Anti-interferon-alfa 2 and SICAM-1 Activities in the Sera of Viral Hepatitis B and C Patients Treated with Human Recombinant Interferon-alfa 2.
Warning: These citations may not always be 100% accurate.
